U.S. Markets closed

Parsabiv - Drug Insights with Sales Forecasting, 2019-2021 - ResearchAndMarkets.com

The "Parsabiv - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Parsabiv - Drug Insight, 2019 report provides comprehensive information of the drug, Parsabiv.

It includes drugs overview, Parsabiv mechanism of action, clinical trials, regulatory milestones, deals & Parsabiv's partnerships. It further provides Parsabiv's patents (US & EU) and its API manufacturers details in the United States, Europe, China and India.

It also features the historical and forecasted Parsabiv sales till 2021. The report also throws light on Parsabiv market competition and emerging therapies in the same space as Parsabiv. Parsabiv SWOT analysis is also featured.

Scope of the Report

  • A comprehensive Parsabiv overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Parsabiv Patent information in United States (US) and Europe (EU) has been highlighted
  • Parsabiv API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Parsabiv sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Parsabiv operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Parsabiv SWOT analysis

Reasons to Buy

  • Establish a comprehensive understanding of the drug, Parsabiv
  • Access to Parsabiv API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Parsabiv patents for the major markets- US and EU
  • Understand current and future Parsabiv`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Parsabiv
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Parsabiv
  • Identify opportunities in the same area as with Parsabiv SWOT analysis

Key Topics Covered

1. Report Introduction

2. Parsabiv - Overview

  • Parsabiv Product Description
  • Parsabiv Route of Synthesis
  • Parsabiv Mechanism of Action
  • Parsabiv Pharmacology
  • Parsabiv Pharmacodynamics
  • Parsabiv Pharmacokinetics
  • Parsabiv Adverse Reactions
  • Parsabiv Clinical Trials
  • Parsabiv Regulatory Milestones
  • Parsabiv Development Activities

3. Global API Manufacturers

  • United States
  • Europe
  • China
  • India

4. Product Details

  • United States
  • Europe

5. Parsabiv Global Sales Assessment

  • Parsabiv Sales Global(Historical)
  • Parsabiv Sales Global(Forecasted)

6. Parsabiv Patent Details

7. Parsabiv Market Competition

8. Parsabiv Emerging Therapies

8.1. Drug name: Company name

  • Product Description
  • Research & Development
  • Product Development Activities

9. Parsabiv SWOT Analysis

List of Tables

Table 1: Parsabiv, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Parsabiv Product Details, United States

Table 8: Parsabiv Product Details, Europe

Table 9: Parsabiv, Historical Global Sales till 2017 (in million USD)

Table 10: Parsabiv, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Parsabiv

Table 12: Parsabiv Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Parsabiv

Figure 2: Parsabiv, Historical Global Sales till 2017 (in million USD)

Figure 3: Parsabiv, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Parsabiv

Figure 5: API Manufacturers Region wise

For more information about this report visit https://www.researchandmarkets.com/r/i7bpr

View source version on businesswire.com: https://www.businesswire.com/news/home/20191227005267/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900